$9.11 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 72 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FB | New | FACEBOOK INCcl a | $366,921,000 | – | 2,583,043 | +100.0% | 4.03% | – |
| PLYA | New | PLAYA HOTELS & RESORTS NV | $316,771,000 | – | 30,168,680 | +100.0% | 3.48% | – |
| WAB | New | WABTEC CORP | $246,228,000 | – | 3,156,764 | +100.0% | 2.70% | – |
| SBAC | New | SBA COMMUNICATIONS CORP NEWcl a | $154,972,000 | – | 1,287,463 | +100.0% | 1.70% | – |
| LBTYK | New | LIBERTY GLOBAL PLC | $113,849,000 | – | 3,249,122 | +100.0% | 1.25% | – |
| LBTYA | New | LIBERTY GLOBAL PLC | $112,904,000 | – | 3,147,585 | +100.0% | 1.24% | – |
| MBBYF | New | MOBILEYE N V AMSTELVEEN | $111,134,000 | – | 1,810,000 | +100.0% | 1.22% | – |
| VEON | New | VEON LTDsponsored adr | $42,572,000 | – | 10,434,422 | +100.0% | 0.47% | – |
| LOGM | New | LOGMEIN INC | $39,506,000 | – | 405,185 | +100.0% | 0.43% | – |
| SWC | New | STILLWATER MNG CO | $31,283,000 | – | 1,811,382 | +100.0% | 0.34% | – |
| HW | New | HEADWATERS INC | $30,641,000 | – | 1,305,000 | +100.0% | 0.34% | – |
| VAL | New | VALSPAR CORP | $30,509,000 | – | 275,000 | +100.0% | 0.34% | – |
| IMMU | New | IMMUNOMEDICS INC | $26,883,000 | – | 4,155,000 | +100.0% | 0.30% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $21,595,000 | – | 580,500 | +100.0% | 0.24% | – |
| RYAAY | New | RYANAIR HLDGS PLCsponsored adr ne | $15,245,000 | – | 183,715 | +100.0% | 0.17% | – |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $7,686,000 | – | 257,500 | +100.0% | 0.08% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $5,094,000 | – | 80,000 | +100.0% | 0.06% | – |
| KATE | New | KATE SPADE & CO | $4,878,000 | – | 210,000 | +100.0% | 0.05% | – |
| ALR | New | ALERE INCcall | $3,258,000 | – | 82,000 | +100.0% | 0.04% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $3,188,000 | – | 106,894 | +100.0% | 0.04% | – |
| New | GNC HLDGS INCnote 1.500% 8/1 | $2,133,000 | – | 3,500,000 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.